T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 2,230.00
-45.00 (-1.98%)
Sep 21, 2026, 3:30 PM KST
T&R Biofab Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | -27,712 | -31,951 | -7,679 | -13,419 |
Depreciation & Amortization | 4,897 | 5,034 | 2,404 | 2,156 |
Loss (Gain) From Sale of Assets | -86.26 | -72.86 | 5.8 | 0.14 |
Asset Writedown & Restructuring Costs | - | - | - | 195.49 |
Loss (Gain) From Sale of Investments | 2,044 | -1,474 | 517.37 | -5.26 |
Stock-Based Compensation | 226.92 | 331.98 | 792.02 | 1,347 |
Provision & Write-off of Bad Debts | 96.1 | -462.7 | 792.12 | 542.03 |
Other Operating Activities | 18,997 | 22,963 | -5,237 | 2,105 |
Change in Accounts Receivable | -4,070 | -2,864 | -531.04 | -843.53 |
Change in Inventory | 592.04 | 1,006 | -612.32 | 361.88 |
Change in Accounts Payable | -834.61 | 264.41 | -1,070 | -1.18 |
Change in Unearned Revenue | - | - | 46.9 | - |
Change in Other Net Operating Assets | 3,599 | -239.92 | -1,162 | 597.43 |
Operating Cash Flow | -2,251 | -7,466 | -11,733 | -6,963 |
Operating Cash Flow Growth | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -2,301 | -2,146 | -2,576 | -12,493 |
Sale of Property, Plant & Equipment | 0.58 | 27.3 | - | - |
Cash Acquisitions | - | - | -6,453 | - |
Sale (Purchase) of Intangibles | -105.76 | -18.96 | -232.19 | -237.02 |
Investment in Securities | 1,306 | 1,822 | 22,726 | -25,002 |
Other Investing Activities | 2,905 | 1,966 | 145.27 | 138.24 |
Investing Cash Flow | 1,875 | 1,729 | 11,689 | -37,515 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Long-Term Debt Issued | - | 12,000 | 17,200 | 34,000 |
Short-Term Debt Repaid | - | -100 | - | - |
Long-Term Debt Repaid | - | -37,210 | -25,549 | -6,478 |
Total Debt Repaid | -25,214 | -37,310 | -25,549 | -6,478 |
Net Debt Issued (Repaid) | -25,214 | -25,310 | -8,349 | 27,522 |
Issuance of Common Stock | 22,664 | 22,664 | 34.18 | 2,024 |
Repurchase of Common Stock | -2.12 | -2.12 | - | - |
Other Financing Activities | -526.3 | -532.3 | 0 | 38.42 |
Financing Cash Flow | -3,078 | -3,180 | -3,515 | 29,585 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Foreign Exchange Rate Adjustments | 89.3 | 5.66 | 2.43 | -0.25 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | -0 |
Net Cash Flow | -3,365 | -8,911 | -3,556 | -14,894 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -4,552 | -9,612 | -14,309 | -19,456 |
Free Cash Flow Growth | - | - | - | - |
Free Cash Flow Margin | -13.91% | -35.64% | -293.60% | -374.22% |
Free Cash Flow Per Share | -101.01 | -300.63 | -553.45 | -764.65 |
Levered Free Cash Flow | 19,410 | -15,318 | -19,550 | - |
Unlevered Free Cash Flow | 22,470 | -11,516 | -17,631 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 3,156 | 3,342 | 860.99 | 191.13 |
Cash Income Tax Paid | - | -78.52 | 3.99 | -14.54 |
Change in Working Capital | -713.97 | -1,834 | -3,328 | 114.61 |